The potential of membrane scaling control by a real-time optimization algorithm was investigated. The effect of antiscalant dosing was evaluated from the induction time measured in glass batch-reactors, and from the operational performance of a lab-scale reverse osmosis (RO) unit and two pilot-scale RO units. Step changes in the antiscalant dosing demonstrated that the accumulation of scaling is ‘paused’ during periods when the optimum dose is applied. This is paramount for the application of a dynamic dosing strategy that may briefly underdose, while searching for the optimum dose. It was found that antiscalant underdose and overdose were both detrimental to RO operation since underdose resulted in membrane scaling, while overdose led to membrane fouling due to calcium-antiscalant deposits. The dosing algorithm was used to minimize antiscalant consumption in two pilot RO units. The algorithm was able to lower the antiscalant doses to 0.2 mg/L and 0.6 mg/L, while the supplier's recommended antiscalant doses were 2.0 mg/L and 4.5 mg/L, respectively. As a result, the algorithm could reduce antiscalant consumption by up to 85–90% for the plants mentioned.

Antiscalants are well known to prevent the precipitation of carbonate and sulphate scales of calcium in reverse osmosis (RO) applications, but according to literature their inhibitory ability against calcium phosphate is not clear. The objective of this study was to investigate if antiscalants, without acid addition, can prevent calcium phosphate scaling in RO systems. Eight calcium phosphate antiscalants from different manufacturers spanning a range of concentrations were tested in batch (in glass reactors) experiments to inhibit the formation of calcium phosphate in synthetic concentrate corresponding to 85% recovery (Ca²⁺ = 765 mg/L, PO₄³⁻ = 13–15 mg/L and pH = 7.6) of a groundwater RO in the Netherlands. Additionally, once-through lab-scale RO tests were conducted where an RO element was fed with synthetic concentrate and the performance of antiscalants was evaluated from the rate of flux-decline in the RO element. Without antiscalant addition, a substantial flux-decline was observed due to the deposition of amorphous calcium phosphate (ACP) on the RO membrane. The tested antiscalants were unable to inhibit the formation of ACP and were incapable of preventing the deposition of the formed ACP particles, since with each antiscalant, the flux of the RO element decreased at least 15% in a 3-h period. Briefly, the available antiscalants, tested in this study, did not provide acceptable inhibition of calcium phosphate scaling in RO applications.

The role of phosphate and humic substances (HS) in preventing calcium carbonate scaling and their impact on antiscalant dose was investigated for a reverse osmosis (RO) system treating anaerobic groundwater (GW) (containing 2.1 mg/L orthophosphate and 6-8 mg/L HS). Experiments were conducted with the RO unit (treating anaerobic GW), and with a once-through lab-scale RO system (operating with artificial feedwater). Additionally, (batch) induction time (IT) measurements were performed with, i) real RO concentrate, and ii) artificial RO concentrates in the presence and absence of phosphate and HS. It was found that at 80% recovery (Langelier saturation index (LSI) 1.7), calcium carbonate scaling did not occur in the RO unit when the antiscalant dose was lowered from 2.2 mg/L (supplier's recommended dose) to 0 mg/L. The IT of the real RO concentrate, without antiscalant, was longer than 168 h, while, at the same supersaturation level, the IT of the artificial concentrate was approximately 1 h. The IT of the artificial concentrate increased to 168 h with the addition of 10 mg/L of phosphate, humic acid (HA), and fulvic acid (FA). Furthermore, in the lab-scale RO tests, the normalized permeability (Kw) of the membrane decreased by 20% in 2 h period when fed with artificial concentrate of 80% recovery containing no phosphate, whereas, with phosphate, no decrease in Kw was observed in 10 h period. These results indicate that phosphate and HS present in the GW prevented calcium carbonate scaling in the RO unit and reduced the use of commercial (synthetic) antiscalants.